ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 806,77
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,525
-0,01%
Bitcoin
71 614,43
0,21%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Bellerophon Therapeutics Inc (BLPH)

  7. Bellerophon Therapeutics Inc (BLPH) Actualités

BLPH

Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BLPH
DateHeureSourceTitreSymboleSociété
30/01/202415h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202420h31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202416h46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
03/01/202419h49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLPHBellerophon Therapeutics Inc
27/10/202316h50Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLPHBellerophon Therapeutics Inc
17/10/202302h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202319h59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202319h59Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
14/08/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLPHBellerophon Therapeutics Inc
29/06/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLPHBellerophon Therapeutics Inc
12/06/202312h45Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202322h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
08/06/202312h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BLPHBellerophon Therapeutics Inc
07/06/202323h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BLPHBellerophon Therapeutics Inc
02/06/202314h56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BLPHBellerophon Therapeutics Inc
26/05/202322h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BLPHBellerophon Therapeutics Inc
25/05/202317h18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BLPHBellerophon Therapeutics Inc
15/05/202322h47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202314h39Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202314h34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BLPHBellerophon Therapeutics Inc
03/04/202323h47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLPHBellerophon Therapeutics Inc
31/03/202314h31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLPHBellerophon Therapeutics Inc
06/03/202322h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BLPHBellerophon Therapeutics Inc
15/11/202214h45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Bellerophon (BLPH)NASDAQ:BLPHBellerophon Therapeutics Inc
27/09/202218h25TipRanksBLPH (NASDAQ:BLPH) Soars on FDA Nod to Lung Study Change; Street Sees 24x GainsNASDAQ:BLPHBellerophon Therapeutics Inc
12/05/202212h27TipRanksH.C. Wainwright Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
25/04/202214h25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BLPHBellerophon Therapeutics Inc
06/04/202213h40TipRanksBrookline Capital Markets Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
04/01/202222h11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BLPHBellerophon Therapeutics Inc
22/12/202123h15TipRanksBellerophon Stock Has Massive Upside Potential, Says AnalystNASDAQ:BLPHBellerophon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BLPH

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
EU
ORA
Orange
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
EN
Bouygues
EU
AI
Air Liquide
EU
CS
Axa
EU
BEL20
Bel 20
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés